59% increase in sales for Entresto Q1 Top sellers: Cosentyx: $930M (+18%); Gilenya: $772M (+1%); Entresto: $569M (+59%); Lucentis: $487M (-9%); Tasigna: $487M (+12%); Promacta/Revolade: $403M (+31%); Tafinlar + Mekinist: $366M (+23%); Sandostatin: $374M (-5%); https://seekingalpha.com/news/3565105-novartis-entresto-sales-up-59-in-q1-guidance-affirmed
the point is I'm guessing that WE promoted Entresto in Q1 and that sales were WAY up. Nothing like the contract being severed after the best performance ever.
Sales might be up but there is no need for a separate PC sales force. There's just not enough business in PC to justify hundreds of Amplity reps.
so quick question. Do you not think PCP referrals to Cardiology didn’t drive increased sales of Entresto in the cardiovascular offices?
Holy sh#t you really are some kind of stupid. Amplity didn't call on Cardiologists. Novartis reps can create their own referrals. There's no need to employ a separate sales force to do that.
I don’t understand why so many Amplity people don’t get the concept of a contract sales force. I don’t care about the what if’s? And how about thats? Novartis looked at their business model and decided it was time to cut ties. Boom! End of story. Why is everyone so butt hurt and acting like it’s unfair? It works for Novartis, so it was done. This ain’t Pretty Woman, the prostitute doesn’t become the wife in this story
Me thinks thou dost protest too much.... Why in the world would you be on the board of a contract salesforce that was ended over 6 weeks ago???!!!??? It seems, for some reason, you just can't let go. What does that say about you?
